Minimal Important Difference in Voice Handicap Index–10

Misono, Stephanie; Yueh, Bevan; Stockness, Ali; House, Meaghan E; Marmor, Schelomo

doi:10.1001/jamaoto.2017.1621

Cited by 53 publications

(64 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In patients with vocal fold paralysis, an improvement of 4 points on the VHI‐10 scale has been suggested to be the minimal clinically important difference that results in a perceivable voice change . Misono et al also reported on patients with a variety of vocal fold disorders and found that the minimal important difference on the VHI‐10 scale was 6 points . Currently, these are the only reference values to indicate a clinically significant voice improvement that is notable by patients.…”

Section: Discussionmentioning

confidence: 99%

“…16 Misono et al also reported on patients with a variety of vocal fold disorders and found that the minimal important difference on the VHI-10 scale was 6 points. 17 Currently, these are the only reference values to indicate a clinically significant voice improvement that is notable by patients. In the fat-injection group, only half of the patients who were improved at their final visit did so by at least 4 points on the VHI-10 scale.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Voice Outcomes of Lipoinjection Versus Medialization Laryngoplasty for Nonparalytic Glottic Insufficiency

2018

View full text Add to dashboard Cite

Objective To compare voice outcomes of autogenous fat injection versus medialization laryngoplasty in patients with glottic insufficiency due to vocal fold paresis or atrophy. Methods A retrospective review was performed from 2009 to 2017 of all patients who underwent lipoinjection or medialization laryngoplasty (ML) for glottic insufficiency. Charts were reviewed for demographic information, preoperative diagnosis, surgical intervention, Voice Handicap Index‐10 (VHI‐10) and Glottal Function Index (GFI) scores, follow‐up time (minimum 3 months), and concomitant voice therapy. Results Eighty‐three patients were initially identified and limited to 28 based on the inclusion/exclusion criteria. Thirty‐five procedures were performed with a total of 15 fat injections and 20 MLs. The mean age was 60.7 years in the lipoinjection group and 55.6 years in the ML group. There was no significant difference in pretreatment VHI‐10 scores between the two groups. Using the lowest recorded voice scores during the follow‐up period, both groups had a significant decrease (P < 0.05) compared to preoperative scores (VHI‐10: fat decreased from 27.8 to 14.2, ML decreased from 30.5 to 9.1; GFI: fat decreased from 13.7 to 5.27, ML decreased from 13.6 to 4.6). When evaluating the entire follow‐up period (median 19 months in fat group, 16.3 months in ML), only the ML group maintained a significant improvement in VHI‐10 (median delta 14.5) and GFI (median delta 7) compared to preoperative scores. Conclusion Although both autogenous fat injection and ML result in improved voice scores in the short term, the effect of fat injection appears to be limited, as evidenced by worsening VHI‐10 and GFI scores over time. Level of Evidence 4 Laryngoscope, 129:1164–1168, 2019

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Voice Outcomes of Lipoinjection Versus Medialization Laryngoplasty for Nonparalytic Glottic Insufficiency

2018

View full text Add to dashboard Cite

show abstract

“…The test-retest reliability was excellent for patients and good for controls indicating a reliable questionnaire, suitable for longitudinal studies. The patient group and the control group had changes in scores of 1.0 ± 3.0 and -0.4 ± 1.5 points respectively in the test-retest interval which is well below the estimated minimal important measurement difference of six points of the original VHI-10 score [15]. Misono et al described limitations of the original VHI-10's ability to distinguish between no change and a small change in the perception of the severity of the voice disorders, and indicated that the questionnaire might not be suitable for evaluating small differences after treatment [15].…”

Section: Discussionmentioning

confidence: 69%

“…The VHI-10 has shown a good correlation to the results of the VHI-30 and has been thoroughly validated by internal consistency, reliability, and test-retest reliability tests [12,13]. In addition, normative values [14] and minimal important differences [15] has been established for the questionnaire and it now exists in multiple languages [16][17][18]. Thus, the VHI-10 is a well-suited clinical tool for patient self-evaluation of the severity of a voice disorder.…”

Section: Introductionmentioning

confidence: 98%

Cross-cultural Adaption and Validation of the Danish Voice Handicap Index

et al. 2019

View full text Add to dashboard Cite

“…). Although the mean post‐IL VHI‐10 scores remained within the abnormal range, the mean improvement was clinically meaningful and consistent with the response rates and magnitude of change observed in previous studies . This suggests that IL assists in more efficient phonation and less muscle effort.…”

Section: Discussionmentioning

confidence: 99%

Injection laryngoplasty as adjunct treatment method for muscle tension dysphonia: Preliminary findings

et al. 2019

View full text Add to dashboard Cite

Objectives This study examined the effectiveness of injection laryngoplasty (IL) in muscle tension dysphonia (MTD) patients who did not fully respond to voice therapy. It was hypothesized that IL would improve voice quality and voice‐related quality of life measures in MTD. Methods A retrospective review was conducted on 37 patients with a primary diagnosis of MTD who underwent IL following a suboptimal response to voice therapy (mean age = 43.0 years; standard deviation [SD] = 13.4; range = 23 to 71). Outcome measures included laryngoscopic signs of supraglottic constriction, Voice Handicap Index‐10 (VHI‐10) scores, maximal phonation time, vowel fundamental frequency (F0), standard deviation of F0 (F0SD), harmonics‐to‐noise ratio (HNR), and smoothed cepstral peak prominence. These were compared between baseline and within 3 months following the IL procedure. Results There was significant decrease in supraglottic constriction. Mean (SD) of VHI‐10 scores decreased from 25.4 (5.7) at baseline to 15.3 (9.3) following IL. This improvement in VHI‐10 was observed in patients with and without baseline glottal insufficiency (GI). Mean (SD) of HNR (decibels) increased from 21.1 (5.4) at baseline to 22.8 (4.3) after IL. Only patients with GI demonstrated a significant improvement in HNR from baseline to post‐IL. No statistically significant differences in other acoustic measures were observed. Conclusions IL resulted in positive changes in voice‐related quality of life in MTD patients with and without GI. Acoustically, only those with GI demonstrated an increase in HNR following IL. Further studies are needed to examine the effects of IL in MTD. Level of Evidence 4 Laryngoscope, 130:980–985, 2020

show abstract

Minimal Important Difference in Voice Handicap Index–10

Cited by 53 publications

References 35 publications

Voice Outcomes of Lipoinjection Versus Medialization Laryngoplasty for Nonparalytic Glottic Insufficiency

Voice Outcomes of Lipoinjection Versus Medialization Laryngoplasty for Nonparalytic Glottic Insufficiency

Cross-cultural Adaption and Validation of the Danish Voice Handicap Index

Injection laryngoplasty as adjunct treatment method for muscle tension dysphonia: Preliminary findings

Contact Info

Product

Resources

About